Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Shortcomings of an unphysiological triggering of oocyte maturation using human chorionic gonadotropin

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Semen quality among young healthy men taking protein supplements

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Ninth-grade school achievement in Danish children conceived following fertility treatment: a population-based cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Psychological stress, stressful life events, male factor infertility, and testicular function: a cross-sectional study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Expression of the Insulin-like Growth Factor System in First- and Second-Trimester Human Embryonic and Fetal Gonads

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Surrogate testes: Allogeneic spermatogonial stem cell transplantation within an encapsulation device may restore male fertility

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Effect of sphingosine-1-phosphate on activation of dormant follicles in murine and human ovarian tissue

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Postnatal germ cell development in cryptorchid boys

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Final maturation of follicles has, in connection with ovarian stimulation and infertility treatment, traditionally been achieved by the administration of a human chorionic gonadotropin (hCG) bolus trigger of 5,000 to 10,000 IU. This trigger serves two purposes: induce oocyte maturation; and serve as luteal phase support owing to its long half-life. It now appears that the hCG bolus trigger is unable to support both these two purposes optimally. In particular, after an hCG trigger, the early luteal phase is hormonally abnormal and different from conditions observed in the natural menstrual cycle: the timing of the initiation of hCG and progesterone rise is much faster after an hCG trigger than in a natural menstrual cycle; the maximal concentrations of hCG and progesterone considerably exceed those naturally observed; and the timing of the peak progesterone concentration after an hCG trigger is advanced several days compared with the natural cycle. Furthermore, the hCG trigger without any follicle-stimulating hormone activity may induce oocyte maturation less efficiently than the combined luteinizing hormone and follicle-stimulating hormone surge normally seen. Collectively, the endometrium is likely to be advanced after an hCG trigger, and the implantation potential is probably not optimal. The precise effect on pregnancy rates after the different progressions of hCG and progesterone concentrations during the early luteal phase has not yet been determined, but more individualized methods using more physiological approaches are likely to improve reproductive outcomes.

OriginalsprogEngelsk
TidsskriftFertility and Sterility
Vol/bind114
Udgave nummer2
Sider (fra-til)200-208
Antal sider9
ISSN0015-0282
DOI
StatusUdgivet - aug. 2020

Bibliografisk note

Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

ID: 61252792